Suppr超能文献

大鼠心脏6-磷酸果糖-1-激酶同工酶的特性分析。

Characterization of the rat heart 6-phosphofructo-1-kinase isozymes.

作者信息

Dunaway G A, Kasten T P

出版信息

J Mol Cell Cardiol. 1985 Oct;17(10):947-57. doi: 10.1016/s0022-2828(85)80075-4.

Abstract

By elution with a discontinuous gradient from QAE-Sephadex, the rat muscle 6-phosphofructo-1-kinase (PFK) isozyme (M4) and the major rat liver PFK isozyme (L4) could be completely separated. Subjecting heart supernatant fluid to this treatment indicated that all of the heart PFK activity was found in the first wash, where M4 eluted, indicating little, if any, L4 was present. However, about 50% of the heart PFK activity was immunoprecipitated by L4 anti-IgG demonstrating the presence of the L-type subunit. A purification procedure was developed which yielded an enzyme preparation of high specific activity and resulted in a recovery of 50% to 60% of the original PFK activity. Three proteins were detected in this PFK preparation that exhibited apparent mol wt of 87 500, 85 000 and 80 000. The 85 000 and 80 000 Dalton components corresponded to the subunits of M4 and L4, respectively. The third protein was thought to be a distinct subunit (C-type) since it exhibited the highest molecular weight and was present in an exhaustively washed immunoprecipitate of purified heart PFK. From seven different heart PFK preparations, the relative distributions of the L-, M-, and C-type subunits were 0.80 +/- 0.1, 4.5 +/- 0.7, and 0.7 +/- 0.1, respectively. A comparison of the kinetic properties of L4, M4, and purified heart PFK isozymes clearly demonstrated that all three preparations exhibited different regulatory properties. In ventricular and atrial preparations the total PFK activity and the relative amounts of each subunit were drastically different suggesting regional differences between the distributions of PFK isozymes and consequently in regulation of PFK activities and glycolysis.

摘要

通过用不连续梯度从QAE-葡聚糖凝胶上洗脱,大鼠肌肉6-磷酸果糖-1-激酶(PFK)同工酶(M4)和大鼠肝脏主要PFK同工酶(L4)能够被完全分离。对心脏上清液进行这种处理表明,所有心脏PFK活性都存在于第一次洗脱液中,M4在此处洗脱,这表明几乎不存在L4(如果存在的话也是极少的)。然而,约50%的心脏PFK活性被L4抗IgG免疫沉淀,这证明了L型亚基的存在。开发了一种纯化方法,该方法产生了具有高比活性的酶制剂,并且原始PFK活性的回收率为50%至60%。在这种PFK制剂中检测到三种蛋白质,其表观分子量分别为87500、85000和80000。85000道尔顿和80000道尔顿的组分分别对应于M4和L4的亚基。第三种蛋白质被认为是一种独特的亚基(C型),因为它具有最高的分子量,并且存在于纯化的心脏PFK的彻底洗涤后的免疫沉淀物中。从七种不同的心脏PFK制剂中,L型、M型和C型亚基的相对分布分别为0.80±0.1、4.5±0.7和0.7±0.1。对L4、M4和纯化的心脏PFK同工酶的动力学性质进行比较清楚地表明,所有三种制剂都表现出不同的调节性质。在心室和心房制剂中,总PFK活性和每个亚基的相对量有很大差异,这表明PFK同工酶分布之间存在区域差异,因此在PFK活性调节和糖酵解方面也存在差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验